Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three nordic countries

Acta Dermato-Venereologica

Volumn 93, Issue 4, 2013, Pages 442-445

  Ragnarson Tennvall, Gunnel ^a   Hjortsberg, Catharina ^a   Bjarnason, Anton ^b   Gniadecki, Robert ^c   Heikkilä, Hannele ^d   Jemec, Gregor B E ^e   Kragballe, Knud ^f   Miller, Iben M ^e   Svensson, Åke ^g  

^a SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c BISPEBJERG HOSPITAL   (Denmark)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e ROSKILDE HOSPITAL   (Denmark)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biological treatment; Psoriasis; Quality of life

Indexed keywords

CORTICOSTEROID; EMOLLIENT AGENT;

ADULT; AGED; ARTICLE; CORTICOSTEROID THERAPY; DENMARK; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; SWEDEN; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; ADULT; AGED; BIOLOGICAL PRODUCTS; DENMARK; DERMATOLOGIC AGENTS; FEMALE; FINLAND; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; PSORIASIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879696902     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1485     Document Type: Article

References (10)

1. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004; 3: 121-128
2. de Korte J, Sprangers M, Mombers F, Bos J. Quality of life in patients with psoriasis: a systematic literature review. J Invest Dermatol 2004; 9: 140-147
3. Fonia A, Jackson K, LeReun C, Grant DM, Barker JNWN, Smith CH. A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis. Br J Dermatol 2010; 163: 807-816
4. Dermbio. A °rsrapport 2008. Annual report for the Danish database initiative for biological treatment of psoriasis in Denmark. 2008 [accessed 29 December, 2011]. Available from: https://dermbio.dk/formidling/Dermbio%20Aarsrapport% 202008%20Final.pdf/view
5. Läkemedelsverket [Medical Products Agency]. [Treatment of psoriasis - treatment guidelines]. Information from Läkemedelsverket 2006; 5: 5-16 (in Swedish)
6. The Finnish Medical Society Duodecim. [Current care guideline on psoriasis and psoriatic arthritis.] Duodecim 2008; 124: 324-346 (in Finnish)
7. Hjortsberg C, Bergman A, Bjarnason A, Heikkilä H, Hjelmgren J, Svensson A, Tennvall GR. Are treatment satisfaction, quality of life, and self-assessed disease severity relevant parameters for patient registries? Experiences from Finnish and Swedish patients with psoriasis. Acta Derm Venereol 2011; 91: 409-414
8. Schmitt-Egenolf M. (PsoReg, Register for systemic treatment of psoriasis. Annual report for September 2007 - August 2008]. PsoReg, Umeå University, 2008 (in Swedish)
9. Flytström I, Stenberg B, Svensson Å, Bergbrant I-M. Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial. Br J Dermatol 2007; 158: 116-121
10. Nyberg F, Osika I, Evengård B. "The laundry bag project" - unequal distribution of dermatological healthcare resources for male and female psoriatic patients in Sweden. Int J Dermatol 2008; 47: 144-149.